35 results on '"Davis, Barry R."'
Search Results
2. Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial
3. Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT
4. Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
5. Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
6. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT
7. Competing Cardiovascular and Noncardiovascular Risks and Longevity in the Systolic Hypertension in the Elderly Program
8. Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
9. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes
10. Dietary Carotenoids and Genetic Instability Modify Bladder Cancer Risk
11. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO trial
12. A Phase I Study of Allogeneic Mesenchymal Stem Cell Therapy in Patients with Heart Failure Secondary to Anthracycline-induced Cardiomyopathy: The Cctrn Stem Cell Injection in Cancer Survivors (Seneca) Trial
13. Magnetic Resonance Imaging–Based Screening Study in a General Population of Adolescents
14. THE U-SHAPED RELATIONSHIP OF BODY MASS INDEX WITH ALL-CAUSE MORTALITY AT EIGHT YEARS IN THE ALLHAT
15. Genetic Modifiers Influencing the Development of Albuminuria in Children with Sickle Cell Anemia
16. Effects of Genetic Polymorphisms on Leukocyte and Neutrophil Counts and Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia
17. TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia
18. Clinical trials in hypertension and related morbidities prediction of survival benefit of clinical trials
19. Effects of Chronic Transfusion Therapy on MRI and MRA in Children with Sickle Cell Anemia at Risk for Primary Stroke: Baseline Imaging from the Twitch Trial
20. Treatment resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
21. Visit to visit variability of the orthostatic response of systolic blood pressure is associated with increased risk of morbid and mortal events
22. Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
23. Extrahepatic Iron Deposition In Chronically Transfused Children With Sickle Cell Anemia – Baseline Findings From The Twitch Trial
24. VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE PREDICTS OUTCOMES MAINLY IN THE ACTIVE TREATMENT GROUP RATHER THAN THE PLACEBO GROUP IN THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM: PATHOPHYSIOLOGIC IMPLICATIONS
25. Results of monotherapy in allhat: on-treatment analyses
26. Blood pressure control by randomized drug group in allhat
27. Risk and impact of incident glucose disorders in hypertensive older adults treated with an ace inhibitor, a diuretic, or a calcium channel blocker: a report from the allhat trial
28. Hodgkin's disease: Correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II
29. Differences in precision of dietary estimates among different population subgroups
30. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP)
31. Data monitoring in clinical trials: The case for stochastic curtailment
32. Visual Acuity of Eyes after Vitrectomy for Retinopathy of Prematurity: Follow-up at 5 1/2 Years
33. Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels
34. Authors' reply
35. New Clinical Challenges in Hypertension Management: The 'Old Silent Killer' Is Alive and Well
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.